Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
Controlled Clinical Trials|February 1, 2003
Unique roles of a data and safety monitoring board in vaccine safety trials with compressed timelines and urgent implicationsDavid Scheifele, Bernard Duval, Gaston De Serres, et al.
The Pediatric Infectious Disease Journal|June 15, 2004
Lack of evidence of encephalopathy related to pertussis vaccine: active surveillance by IMPACT, Canada, 1993-2002Dorothy L Moore, Nicole Le Saux, David Scheifele, et al.
The Pediatric Infectious Disease Journal|June 4, 2005
Nationwide canadian study of hepatitis a antibody prevalence among children eight to thirteen years oldBernard Duval, Gaston De Serres, Jan Ochnio, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 23, 2024
In-host modeling of dengue virus and non-structural protein 1 and the effects of ivermectin in patients with acute dengue feverJunjie Ding, Dumrong Mairiang, Dararat Prayongkul, et al.
The Lancet. Infectious Diseases|October 26, 2017
A genetically inactivated two-component acellular pertussis vaccine, alone or combined with tetanus and reduced-dose diphtheria vaccines, in adolescents: a phase 2/3, randomised controlled non-inferiority trialSirintip Sricharoenchai, Chukiat Sirivichayakul, Kulkanya Chokephaibulkit, et al.
Human Vaccines & Immunotherapeutics|July 13, 2023
Immunogenicity and reactogenicity of heterologous COVID-19 vaccination in pregnant womenChenchit Chayachinda, Kanokwaroon Watananirun, Chayawat Phatihattakorn, et al.
The Pediatric Infectious Disease Journal|February 18, 2010
Postvaccination thrombocytopenia in CanadaLaura J Sauvé, Julie Bettinger, David Scheifele, et al.
Vaccine|February 25, 2021
Immunogenicity and safety profiles of a new MAV/06 strain varicella vaccine in healthy children: A multinational, multicenter, randomized, double-blinded, active-controlled phase III studyUi Yoon Choi, Ki Hwan Kim, Jin Lee, et al.
The Pediatric Infectious Disease Journal|November 7, 2007
Invasive infections caused by haemophilus influenzae serotypes in twelve Canadian IMPACT centers, 1996-2001Athena McConnell, Ben Tan, David Scheifele, et al.
The Pediatric Infectious Disease Journal|June 1, 2012
The effect of funded varicella immunization programs on varicella-related hospitalizations in IMPACT centers, Canada, 2000-2008Ben Tan, Julie Bettinger, Athena McConnell, et al.
Pageof 8